or Try an Advanced Search...

    Regeneron Stocks List

    Symbol Grade Name % Change
    ADVM F Adverum Biotechnologies, Inc. -5.81
    SNY D Sanofi -2.69
    REGN A Regeneron Pharmaceuticals, Inc. 0.97
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major
    Related Stock Lists: Colorectal Cancer Macular Degeneration Pain Adverum Biotechnologies Angiogenesis Animal Health Antibodies Asthma Atopic Dermatitis Biopharmaceutical Biotechnology Bone Breakthrough Therapy Cac 40 Cancer Cardiovascular Disease Cartilage Cholesterol Chronic Kidney Disease Clinical Development

    Related ETFs - A few ETFs which own one or more of the above listed Regeneron stocks.

    Symbol Grade Name Weight
    IBBQ A Invesco Nasdaq Biotechnology ETF 9.68
    IBB B iShares Nasdaq Biotechnology Index Fund 8.59
    BBH B Market Vectors Biotech ETF 8.17
    VIRS A Pacer BioThreat Strategy ETF 7.68
    BIB B ProShares Ultra Nasdaq Biotechnology 6.51
    View all Regeneron ETFs...
    Compare ETFs
    Compare BBH to VIRS Compare IBB to BIB Compare IBBQ to IBB

        Regeneron Stocks Recent News

        Date Stock Title
        Jun 14 REGN Regeneron Pharmaceuticals Wins Injunctions Against Biosimilars to Eye Disease Drug Eylea
        Jun 14 REGN Regeneron wins injunction blocking Samsung Bioepis from launching generic Eylea
        Jun 14 SNY CDC 'preparing for the possibility' bird flu could spread more easily
        Jun 14 REGN Investors in Regeneron Pharmaceuticals (NASDAQ:REGN) have seen stellar returns of 220% over the past five years
        Jun 14 SNY Sanofi: A Leader In Life-Saving Vaccines And Treatments
        Jun 14 SNY Is It Too Late to Buy Novavax Stock?
        Jun 13 SNY Why It's A New Day For COPD Patients — And Regeneron, Sanofi, Verona Stocks
        Jun 13 REGN Why It's A New Day For COPD Patients — And Regeneron, Sanofi, Verona Stocks
        Jun 13 SNY Exploring Three Top Dividend Stocks On Euronext Paris
        Jun 13 REGN REGN, CI, BSX: Which “Strong Buy” Healthcare Stock Is the Best Bet?
        Jun 12 SNY Sanofi: Information concerning the total number of voting rights and shares – May 2024
        Jun 12 REGN Why Big-Name Biotech Regeneron Pharma Just Joined The 1,000-Club
        Jun 12 SNY A Life Expansion Revolution Is Coming: 3 Stocks That Could Lead the Charge
        Jun 11 REGN Regeneron wins injunction blocking Mylan from launching generic version of its eye drug Eylea (update)
        Jun 11 SNY Regeneron (REGN), SNY Win FDA Nod for Kevzara Label Expansion
        Jun 11 REGN Regeneron (REGN), SNY Win FDA Nod for Kevzara Label Expansion
        Jun 11 SNY Is Sanofi SA (NASDAQ:SNY) the Best International Pharmaceutical Dividend Stock?
        Jun 11 REGN Regeneron Pharmaceuticals, Inc. (REGN) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)
        Jun 11 ADVM Adverum Biotechnologies Announces Appointments of Dr. Rabia Gurses Ozden as Chief Medical Officer and Dr. Szilárd Kiss as a Member of the Board of Directors
        Jun 11 REGN Regeneron, Sanofi win FDA label expansion for arthritis therapy Kevzara
        Related Industries: Biotechnology Drug Manufacturers - Major
        Related Stock Lists: Colorectal Cancer Macular Degeneration Pain Adverum Biotechnologies Angiogenesis Animal Health Antibodies Asthma Atopic Dermatitis Biopharmaceutical Biotechnology Bone Breakthrough Therapy Cac 40 Cancer Cardiovascular Disease Cartilage Cholesterol Chronic Kidney Disease Clinical Development
        Regeneron

        Regeneron Pharmaceuticals, Inc. is a biotechnology company headquartered in Eastview, near Tarrytown, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities (thus the name), it branched out into the study of both cytokine and tyrosine kinase receptors.

        More about Regeneron
        Browse All Tags